Sun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026

SPARC/Sec/SE/2026-27/44 October 22, 2026 National Stock Exchange of India Ltd., BSE Limited, Exchange Plaza, 5th Floor, Market Operations Dept. Plot No. C/1, G Block, P. J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 051. Mumbai - 400 001. Scrip Symbol: SPARC Scrip Code: 532872 Dear Sir/ Madam, Sub: Intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Board Meeting and Connected Matters Board Meeting: This is to inform that the meeting of the Board of Directors of Sun Pharma Advanced Research Company Ltd is scheduled to be held on Monday, November 02, 2026, inter alia; to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026. Trading Window Closure: Further, pursuant to the Code of Conduct of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in shares of the Company as intimated vide our letter dated September 25, 2026 has been closed for all the Directors/KMPs/Designated Employees/Connected Persons from October 01, 2026 and shall remain closed till the end of 48 hours after the said Financial Results are declared and submitted to the Stock Exchanges. This is for your information and record. Thanking you, Yours faithfully, For Sun Pharma Advanced Research Company Ltd. Kajal Damania Company Secretary and Compliance Officer